| Description |
The GPCR Congress 2009, presented by Oxford Global Conferences, will provide a first class educational and networking opportunity for over 100 attendees from leading pharmaceutical, biotechnology and academic institutions in the UK, Europe and the US. It will take place on the 29 and 30th October 2009, in Berlin Germany and will be co-located with the 2nd Annual Proteins Congress.
Over two days the comprehensive scientific conference programme will feature keynote addresses, case study presentations, panel and roundtable discussions from over 35 speakers giving insight on into GPCR Discovery techniques. Topics being covered at the Congress include:-
STRUCTURE & IN SILICO MODELLING
Focus upon the optimization of all areas of GPCR drug design including structure, mechanism, SAR, protein and ligand structure based drug design and molecular and in silico modelling
GPCR MODULATION
Closer studies into various aspects of GPCR’s including allosteric modulations from both a chemistry and biology aspect, dimerisation and oligomerisation
GPCR SCREENING
Examining the implementation of GPCR screening methods, HTS, HCS as well as exploring the roles of cell and label free screening, assay technology as well as determining cost effective assay formats.
GPCR SIGNALLING & DISCOVERY GPCR PROGRAMMES
Latest approaches to other important aspects of GPCR’s - including the role of signaling and trafficking, functional selectivity, polypharmacology and Drug Discovery Programmes
Confirmed speakers at the event include:-
• Steve Garland, Group Leader Lead Generation, GSK
• Sandra Siehler, Center for Proteomic Chemistry, Novartis Institutes for BioMedical Research
• Martin Lohse. Institute of Pharmacology and Toxicology, University of Wurzburg
• Evi Kostenis, Head of Department, Director of Institute, University of Bonn
RESERVED
• Steve McKeown, Chemistry Team Leader, Novartis
• Stephen Hill, Director, Institute of Cell Signalling, University of Nottingham
• Oliver Nayler, Director, Head Molecular Biology, Actelion
• Gebhard Schertler, Senior Scientist and Group Leader Structural Studies MRC Lab of Molecular Biology, Cambridge
• Christoph Ullmer, Scientific Specialist, Discovery Research Metabolic Diseases, F. Hoffmann-La Roche
• Rochdi Bouhelal, Research Investigator,Centre for Proteomic Chemistry, Novartis
• Senior Representative Schering Plough
• Senior Representative Addex Pharmaceuticals
• Senior Representative Heptares
Early bird discounts are available by quoting “GPCRDEL09”. For information on sponsorship please email sponsorship@oxfordglobal.co.uk or call +44(0) 1865 304925 www.gpcr-congress.com.
|
|
